• Test Code:
  • Department:
  • Test Synonyms:
    ANGPTL3APOBMTTPPCSK9
  • CPT Code(s):
    Contact KDL for billing information
Background:

Lipid disorders comprise a group of heterogenic conditions often with overlapping clinical features such as abnormal levels of HDL, LDL, or triglycerides. Hypolipidemia is characterized by low levels of total, LDL and HDL cholesterol measured in serum. These may cause complications that include hyperthyroidism, recurrent infections and absorption of fat soluble vitamins. Specific conditions also include autosomal recessive abetalipoproteinemia and autosomal dominant hypobetalipoproteinemia, as well as hypocholesterolemia. This next-generation sequencing test is designed to detect mutations in the coding regions for 4 genes associated to hypolipidemia and hypocholesterolemia.

Reasons for Referral:

  • Abnormally low levels of total serum cholesterol
  • Clinical presentation consistent with a lipid disorder
  • Positive family history (targeted testing is available if familial mutation is known)
  • Carrier testing
For detailed information and ordering instructions, please refer to Full Gene Analysis (1240).

Genes may be added or removed from the list below if clinically indicated.

Hypolipidemia and Hypocholesterolemia Panel (4 genes): 
ANGPTL3, APOB, MTTP, PCSK9

Methodology:

 

Specimen Requirements:

For detailed information and ordering instructions, please refer to Full Gene Analysis (1240).

Test Performed (Days):

Turn Around Time:

Shipment Sensitivity Requirements:

For detailed information and ordering instructions, please refer to Full Gene Analysis (1240).

References:

Additional Info:

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More